Fetal mortality · pregnant women with fetal growth restriction
1 finding from 1 review
Any known death after randomisation (fetal, neonatal, child, child as adult) · women at risk of preterm birth
It is very uncertain whether dexamethasone: oral changes any known death after randomisation (fetal, neonatal, child, child… compared with intramuscular – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
Any known death after randomisation (fetal, neonatal, child, child as adult) · women at risk of preterm birth
It is very uncertain whether betamethasone acetate plus phosphate changes any known death after randomisation (fetal, neonatal, child, child… compared with betamethasone phosphate – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
Any known death after randomisation (fetal, neonatal, child, child as adult) · women at risk of preterm birth
It is very uncertain whether betamethasone 12‐hourly changes any known death after randomisation (fetal, neonatal, child, child… compared with 24‐hourly dosing – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
Any known death after randomisation (fetal, neonatal, child, child as adult) · women at risk of preterm birth
Dexamethasone showed no clear difference in any known death after randomisation (fetal, neonatal, child, child… compared with betamethasone – fetal/neonatal outcomes (moderate certainty).
1 finding from 1 review
Termination of pregnancy for fetal abnormality · Fetal ultrasound assessment before 24 weeks' gestation
Second trimester routine probably leads to higher termination of pregnancy for fetal abnormality compared with selective ultrasound (moderate certainty).
1 finding from 1 review
Fetal or neonatal mortality · women with a non‐reassuring fetal heart trace during labour but without uterine tachysystole
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women with fetal distress for whom the decision had been made to delivery by emergency caesarean section
Summary of findings for selective ß2‐adrenergic agonist showed no clear difference in fetal or neonatal mortality compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Fetal or neonatal mortality · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in fetal or neonatal mortality compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Fetal or neonatal mortality · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resolution of fetal distress on FHR tracing · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
It is very uncertain whether summary of findings for subcutaneous terbutaline changes resolution of fetal distress on FHR tracing compared with IV magnesium sulphate (very low certainty).
1 finding from 1 review
Fetal or neonatal mortality · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women in labour with signs of fetal distress and a fetal scalp pH < 7.25, for whom the decision had been made for emergency delivery
1 finding from 1 review
Fetal or neonatal mortality · women with severe intrapartum fetal bradycardia
1 finding from 1 review
Detection of fetal abnormality before 24 weeks' gestation · Fetal ultrasound assessment before 24 weeks' gestation
Routine/revealed probably leads to higher detection of fetal abnormality before 24 weeks' gestation compared with selective/concealed ultrasound (moderate certainty).
1 finding from 1 review
Caesarean section · women with gestational diabetes mellitus and their babies
Fetal biometry showed no clear difference in caesarean delivery compared with maternal glycaemic values (low certainty).
1 finding from 1 review
Maternal Hypoglycaemia ‐ not reported · women with gestational diabetes mellitus and their babies
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypertensive disorders of pregnancy · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes hypertensive disorders of pregnancy (including pre‐eclampsia,… compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Development of T2DM in mother ‐ not reported · women with gestational diabetes mellitus and their babies
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Large‐for‐gestational age · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes large‐for‐gestational age compared with maternal glycaemic values (very low certainty).
1 finding from 1 review